文献速递临床试验与 GCP

超声引导与触诊法置入外周静脉套管针在初次髋或膝关节置换术前患者的比较:一项随机对照试验的研究方案

Comparison of ultrasound-guided and palpation-inserted peripheral venous cannula in -patients before primary hip or knee arthroplasty: study protocol for a randomized controlled trial.
PubMed 文献 · Trials · 2023-07-21

该研究为研究者发起的、前瞻性、随机、单中心对照试验,计划纳入200例择期初次全髋或全膝关节置换术患者,随机分为触诊组(C组)和超声引导组(USG组)。主要终点为超重/肥胖(BMI≥25)患者中两种置入方法所需穿刺尝试次数的比较,次要终点为术后5天内套管针用于静脉治疗失败率,三级终点包括可采血套管针比例、置入时间、针尖重新定向次数及再置入需求。

要点

  • 研究比较超声引导与触诊法置入外周静脉套管针在关节置换术前患者中的效果。
  • 主要终点为超重/肥胖(BMI≥25)患者中两种方法的穿刺尝试次数。
  • 次要终点为术后5天内套管针用于静脉治疗的失败率。

核心结论

  • 研究者假设超声引导血管通路在套管针短期通畅性及经套管针采血方面亦更优,研究完成后将回答围术期使用超声引导血管通路是否具有临床相关性。
  • 若假设得到证实,该发现可能有助于在围术期更广泛地实施超声引导外周血管通路。

研究设计与样本

  • 研究者发起的、前瞻性、随机、单中心对照试验,计划随机分配200例择期初次全髋或全膝关节置换术患者至触诊组(C组)或超声引导血管通路组(USG组)。

关键数值与推荐

  • 主要终点为超重/肥胖(BMI≥25)患者中超声引导与触诊置入外周静脉套管针所需穿刺尝试次数的比较。
  • 次要终点为术后5天内外周静脉套管针用于静脉治疗的失败率。
  • 三级终点包括术后5天内可确保采血的长外周静脉套管针比例、各组置入所需时间、两组针尖重新定向次数及两组因任何原因需再置入外周静脉套管针的情况。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: More than 2 billion peripheral vascular cannulas are introduced globally each year. It is the most frequently performed invasive procedure in medicine worldwide. There is a group of patients with difficult intravenous access (DIVA). In experts' hands, ultrasound-guided vascular access appears to be a significantly better method. Investigators hypothesize that UGVA is superior also in short-term patency of cannula and even for blood draw through cannula. Repeated cannula pricks in the operating room setting not only puts a lot of stress on the patient and medical staff, but they also waste OR time. METHODS: This investigator-initiated prospective randomized monocentric controlled trial is designed to randomly allocate 200 patients undergoing elective primary total joint arthroplasty of hip or knee to one of two groups as follows: Group C (control group) - peripheral venous cannula insertion by palpation or Group USG (intervention) - cannula insertion by ultrasound-guided vascular access. Our primary endpoint is to compare the number of attempts for ultrasound-guided insertion of the peripheral venous cannula with common palpation insertion of the peripheral venous cannula in overweight/obese patients (BMI ≥ 25). The secondary endpoint is a failure rate of the peripheral venous cannula to administer intravenous therapy up to 5 days postoperatively. Tertiary endpoints include a portion of long PVCs that are able to ensure blood draw up to 5 days postoperatively, time needed to insert PVC in each group, number of needle tip redirections in both groups, and reinsertion of PVC needed in both groups for any reason. DISCUSSION: This study is pragmatic and is looking for clinically relevant data. After completion, it will answer the question of whether it is clinically relevant to use ultrasound-guided vascular access in the context of not only short-term benefit of insertion, but also up to 5 days after insertion. Also, if this method can ensure blood draw through a peripheral vein cannula, it can save resources in the perioperative period - valuable especially considering the ongoing shortage of medical staff worldwide. If this hypothesis is confirmed, this finding could contribute to more widespread implementation of ultrasound-guided peripheral vascular access in the perioperative period. TRIAL REGISTRATION: ClinicalTrials.gov NCT05156008. Registered on 13.12.2021.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Hlasny J, Alberty R, Hlavac M, et al. Comparison of ultrasound-guided and palpation-inserted peripheral venous cannula in -patients before primary hip or knee arthroplasty: study protocol for a randomized controlled trial. Trials. 2023. PMID: 37480132. doi:10.1186/s13063-023-07459-x

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。